Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Cesarean Section Thromboprophylaxis Pilot Study
NCT00225108Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jul 2002
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tinzaparin in deep vein thrombosis (DVT), venous thromboembolism (VTE), sponsored by Ottawa Hospital Research Institute. Started Jul 2002; status: completed.
02
Drugs
tinzaparin
03
Conditions
deep vein thrombosis (DVT)venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00225108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00225108.